AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)
AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)

Cash Flow ACOR Quote Acorda Ther

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome -35 -223 34
Depreciation 22 23 11
DeferredIncomeT -11 -54 -15
StockBasedCompe 36 33 21
AccountsReceiva -20 -29 58
InventoryCS -7 6 8
AccountsPayable 38 -4 -3
OtherWorkingCap -3 -3 0
OtherNonCashIte 8 48 53
NetCashProvided 35 96 151
InvestmentsInPP -6 -14 -33
AcquisitionsNet 0 0 0
PurchasesOfInve -40 0 -249
SalesMaturities 240 0 98
PurchasesOfInta -267 -1 -1
OtherInvestingA 0 0 0
NetCashUsedForI -74 -11 -177
DebtIssued 0 0 0
DebtRepayment 0 -2 -1
CommonStockIssu 76 10 15
CommonStockRepu 0 0 -2
DividendPaid 0 0 0
OtherFinancingA -30 54 0
NetCashProvided 46 62 13
NetChangeInCash 5 149 -14
CashAtBeginning 153 159 308
CashAtEndOfPeri 159 307 294
Acorda Therapeutics Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Acorda Therapeutics Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.